Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|May 6, 2008
Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growthHannu Mönkkönen, Johanna Kuokkanen, Ingunn Holen, et al.
Endocrine-Related Cancer|July 24, 2014
Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bonePenelope D Ottewell, Ning Wang, Joshua Meek, et al.
International Journal of Cancer|January 22, 2015
OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bonePenelope D Ottewell, Ning Wang, Hannah K Brown, et al.
International Journal of Molecular Sciences|September 29, 2018
Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast CancerHannah K Brown, Gloria Allocca, Penelope D Ottewell, et al.
Breast Cancer Research : BCR|May 29, 2012
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivoIngunn Holen, Jacob Whitworth, Faith Nutter, et al.
Journal of Vascular Research|May 1, 2010
Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel?Maria Michailidou, Hannah K Brown, Diane V Lefley, et al.
Breast Cancer Research : BCR|March 8, 2017
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cellsJessalyn M Ubellacker, Marie-Therese Haider, Molly J DeCristo, et al.
Breast Cancer Research and Treatment|September 30, 2011
Combination therapy inhibits development and progression of mammary tumours in immunocompetent micePenelope D Ottewell, Hannah K Brown, Mark Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivoPenelope D Ottewell, Ning Wang, Hannah K Brown, et al.
Pageof 9